207 related articles for article (PubMed ID: 24421046)
1. Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.
Gupta S; Silva TS; Osizugbo JE; Tucker L; Spratt HM; Garg NJ
Infect Immun; 2014 Apr; 82(4):1382-9. PubMed ID: 24421046
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
Gupta S; Garg NJ
PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
[TBL] [Abstract][Full Text] [Related]
3.
Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
Front Immunol; 2019; 10():1456. PubMed ID: 31293599
[No Abstract] [Full Text] [Related]
4. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
[TBL] [Abstract][Full Text] [Related]
5. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
Bhatia V; Garg NJ
Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
[TBL] [Abstract][Full Text] [Related]
6. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.
Gupta S; Garg NJ
PLoS One; 2013; 8(3):e59434. PubMed ID: 23555672
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
[TBL] [Abstract][Full Text] [Related]
8. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
[TBL] [Abstract][Full Text] [Related]
9. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.
Gupta S; Wan X; Zago MP; Sellers VC; Silva TS; Assiah D; Dhiman M; Nuñez S; Petersen JR; Vázquez-Chagoyán JC; Estrada-Franco JG; Garg NJ
PLoS Negl Trop Dis; 2013; 7(1):e2018. PubMed ID: 23350012
[TBL] [Abstract][Full Text] [Related]
11. Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
Aparicio-Burgos JE; Zepeda-Escobar JA; de Oca-Jimenez RM; Estrada-Franco JG; Barbabosa-Pliego A; Ochoa-García L; Alejandre-Aguilar R; Rivas N; Peñuelas-Rivas G; Val-Arreola M; Gupta S; Salazar-García F; Garg NJ; Vázquez-Chagoyán JC
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003625. PubMed ID: 25853654
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease.
Chowdhury IH; Koo SJ; Gupta S; Liang LY; Bahar B; Silla L; Nuñez-Burgos J; Barrientos N; Zago MP; Garg NJ
J Innate Immun; 2017; 9(2):203-216. PubMed ID: 27902980
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ
PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470
[TBL] [Abstract][Full Text] [Related]
15. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
16. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
Garg N; Tarleton RL
Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
[TBL] [Abstract][Full Text] [Related]
17. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
Bhatia V; Sinha M; Luxon B; Garg N
Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
[TBL] [Abstract][Full Text] [Related]
18. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
19. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
20. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
